DocMorris AG Cash Flow Conversion Efficiency

Latest as of June 2025: -0.116x

DocMorris AG cash flow conversion efficiency. Based on the latest financial reports, DocMorris AG (DOCM) has a cash flow conversion efficiency ratio of -0.116x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-55.66 Million ≈ $-70.36 Million USD) by net assets (CHF480.35 Million ≈ $607.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of DocMorris AG (2010–2024)

Cash flow conversion efficiency of DocMorris AG from 2010 to 2024. This chart illustrates how DocMorris AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for DocMorris AG for real-time trading data and today's change.

DocMorris AG Cash Flow Conversion Ratio Explained

DocMorris AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

DocMorris AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DocMorris AG ranked by their cash flow conversion efficiency. Also see DOCM company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Shanghai Hile Bio-tech SHG:603718	-0.001x
Nanjing Julong Science & Technology Co Ltd Class A SHE:300644	0.025x
Sermsang Power Corporation Public Company Limited BK:SSP	0.058x
Nacity Property Service Co Ltd SHG:603506	-0.083x
Lands’ End Inc NASDAQ:LE	-0.025x
First United Corporation NASDAQ:FUNC	0.023x
Nbond Nonwovens SHG:603238	0.037x
Ajmera Realty & Infra India Limited NSE:AJMERA	0.028x

Annual Cash Flow Conversion Efficiency for DocMorris AG (2010–2024)

The table below shows the annual cash flow conversion efficiency of DocMorris AG from 2010 to 2024. Review DOCM free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CHF340.11 Million ≈ $430.00 Million	CHF-26.60 Million ≈ $-33.63 Million	-0.078x	+61.48%
2023-12-31	CHF430.53 Million ≈ $544.31 Million	CHF-87.42 Million ≈ $-110.52 Million	-0.203x	+26.79%
2022-12-31	CHF350.78 Million ≈ $443.48 Million	CHF-97.29 Million ≈ $-123.00 Million	-0.277x	-2.96%
2021-12-31	CHF484.92 Million ≈ $613.07 Million	CHF-130.63 Million ≈ $-165.15 Million	-0.269x	-112.18%
2020-12-31	CHF531.74 Million ≈ $672.26 Million	CHF-67.51 Million ≈ $-85.35 Million	-0.127x	+37.64%
2019-12-31	CHF405.54 Million ≈ $512.71 Million	CHF-82.57 Million ≈ $-104.39 Million	-0.204x	-171.83%
2018-12-31	CHF443.61 Million ≈ $560.84 Million	CHF-33.23 Million ≈ $-42.01 Million	-0.075x	+0.85%
2017-12-31	CHF294.22 Million ≈ $371.98 Million	CHF-22.23 Million ≈ $-28.10 Million	-0.076x	+43.30%
2016-12-31	CHF103.81 Million ≈ $131.24 Million	CHF-13.83 Million ≈ $-17.48 Million	-0.133x	-151.38%
2015-12-31	CHF72.78 Million ≈ $92.01 Million	CHF18.87 Million ≈ $23.86 Million	0.259x	+178.59%
2014-12-31	CHF77.35 Million ≈ $97.79 Million	CHF7.20 Million ≈ $9.10 Million	0.093x	+240.84%
2013-12-31	CHF73.38 Million ≈ $92.77 Million	CHF2.00 Million ≈ $2.53 Million	0.027x	-88.74%
2012-12-31	CHF85.79 Million ≈ $108.46 Million	CHF20.81 Million ≈ $26.31 Million	0.243x	+607.10%
2011-12-31	CHF81.80 Million ≈ $103.42 Million	CHF2.81 Million ≈ $3.55 Million	0.034x	-80.54%
2010-12-31	CHF79.19 Million ≈ $100.12 Million	CHF13.96 Million ≈ $17.65 Million	0.176x	--

About DocMorris AG

SW:DOCM Switzerland Pharmaceutical Retailers

Market Cap

$977.55 Million

CHF773.21 Million CHF

Market Cap Rank

#14819 Global

#161 in Switzerland

Share Price

CHF15.91

Change (1 day)

-3.16%

52-Week Range

CHF3.98 - CHF16.43

All Time High

CHF509.00